Home›Stock Screener›Mono Pharmacare

Mono Pharmacare Share Price Today | Stock Price & Mono Pharmacare Share Screener

MONOPHARMA Pharmaceuticals

Track the current Mono Pharmacare share price and stock price live with TickJournal's free stock screener. Check Mono Pharmacare 52-week for the annual price range and momentum. Use the Mono Pharmacare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Mono Pharmacare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Mono Pharmacare Market Cap ₹15.11 Cr.
MONOPHARMA P/E Ratio (TTM) -
Mono Pharmacare P/B Ratio 0.48
EPS (TTM) ₹0.41
Dividend Yield -
Debt to Equity 1.75
MONOPHARMA 52 Week High -
Mono Pharmacare 52 Week Low -
Operating Margin -
Profit Margin -
MONOPHARMA Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹122.00
Total Equity ₹32.00

Mono Pharmacare Share Price Chart

Track the current stock price of Mono Pharmacare with an interactive chart. Analyse MONOPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Mono Pharmacare stock quote in one place.

Mono Pharmacare Company Profile - Fundamental Screener

Screen Mono Pharmacare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MONOPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0OIP01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0OIP01012

Mono Pharmacare Balance Sheet Screener

Screen MONOPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹122, up from ₹110 in 2025.

Latest statistics put total assets at ₹122 and shareholder funds at ₹32, with a leverage ratio of 1.75.

Item 2026 2025 2024 2023

Assets

Total Assets 122 110 81 63
Current Assets 121 109 80 61
Fixed Assets 1 1 1 1

Liabilities

Total Liabilities 0 0 0 0
Current Liabilities 27 26 17 15
Non-Current Liabilities 0 0 0 0

Shareholders' Equity

Total Equity 32 31 28 14
Share Capital 18 18 18 12
Reserves & Surplus 14 14 10 1

Mono Pharmacare Income Statement Screener - Profit & Revenue Analysis

Screen Mono Pharmacare income statement and profit fundamentals. Analyze MONOPHARMA quarterly results. Mono Pharmacare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹166 and net profit of ₹1.

Item None-None 2026-March 2025-March 2024-March 2023-March

Revenue and Expenses

Revenue 0 166 169 122 33
Expenses 0 161 161 116 31

Operating Costs and Margins

EBITDA 0 5 9 6 2
Operating Profit % 0.00% 3.00% 5.00% 5.00% 7.00%
Depreciation 0 0 0 0 0
Interest 0 3 4 3 1

Profit and Earnings

Profit Before Tax 0 1 5 3 1
Tax 0 0 1 1 0
Net Profit 0 1 3 3 1
EPS 0.00 0.41 1.75 1.59 0.79

Mono Pharmacare Cash Flow Screener - Liquidity Fundamentals

Screen MONOPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3.

Over the same period, investing activities provided ₹0 and financing activities used ₹2.

Item 2026-March 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities 3 -4 -9 -40
Investing Activities 0 0 0 -1

Financing and Net Cash

Financing Activities -2 5 8 41
Net Cash Flow 0 0 0 0

Mono Pharmacare Shareholding Pattern Screener

See Mono Pharmacare shareholding pattern with promoter, FII, and DII holdings. Check Mono Pharmacare promoter holding and ownership changes for MONOPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 56.72%, foreign institutions 0.00%, domestic institutions 0.00% and the public 33.28%, spread across 529 shareholders.

The shareholder count was 529 in 2026-Mar, compared with 478 in 2025-Mar.

Item 2026-Mar 2025-Mar 2025-Sept 2024-Mar 2024-Sept 2023-Apr 2023-Aug 2023-Sept

Promoter Holding

Promoter Holding 56.72% 56.72% 56.72% 56.72% 56.72% 81.03% 81.03% 56.72%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 33.28% 35.60% 34.48% 36.69% 35.27% 0.00% 0.00% 38.13%
Other Holding 10.00% 7.68% 8.80% 6.59% 8.01% 18.97% 18.97% 5.14%
Shareholder Count 529 478 514 418 463 17 17 972

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Mono Pharmacare. Mono Pharmacare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Mono Pharmacare.

Mono Pharmacare Stock Index Membership - Nifty & Sensex

See which indices include Mono Pharmacare stock. Check MONOPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Mono Pharmacare is not part of any tracked indices.
Only major market indices are tracked in our system.

Mono Pharmacare Market Events Screener - Corporate Actions

Get Mono Pharmacare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Mono Pharmacare stock events that may affect MONOPHARMA share price, along with derivatives, futures and options activity and sector gainers.

7 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 16, 2026, with a record date of July 16, 2026.

It is followed by Extraordinary General Meeting dated June 30, 2026 and Extraordinary General Meeting dated April 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-07-16 2026-07-16 Quarterly Result Announcement NA -6.82%
2026-06-30 2026-06-30 Extraordinary General Meeting NA -3.06%
2026-04-30 2026-04-30 Extraordinary General Meeting NA 18.83%
2025-11-29 2025-11-29 Quarterly Result Announcement NA 10.25%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 11.83%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -2.23%
2024-09-30 2024-09-30 Annual General Meeting NA 8.53%

Mono Pharmacare Competitors Screener - Peer Stocks Comparison

Screen MONOPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 440,494 36.83 61,674 12.69% 11,565 47.42
Divis Laboratories 247,019 86.00 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 183,337 86.72 13,886 20.34% 2,138 48.14
Zydus Life Science 115,601 25.96 27,658 17.64% 5,026 61.81
Cipla 109,489 33.29 29,045 2.24% 3,870 44.03
Laurus Labs 107,084 98.39 6,868 22.01% 890 58.00
Mankind Pharma 104,087 50.84 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 103,492 32.77 35,059 3.90% 4,158 69.59
Aurobindo Pharma 96,393 26.41 34,145 5.56% 3,503 54.69
Lupin 93,694 16.97 29,039 26.75% 5,356 34.02

Mono Pharmacare Company Announcements - News & Reports Screener

Screen MONOPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 0.48. Market capitalisation stands at ₹15.11 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 4 balance sheet periods, 5 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.